Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023 - Top-Institutions - MDSpire

Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023

  • By

  • Ziyue Wang

  • Shuai Wang

  • Guomu Liu

  • Hao Wu

  • Yuguo Chen

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Institute for Health Metrics and Evaluation
    Institute for Health Metrics and Evaluation

    Seattle, Washington

    Key Differentiators

    • Oncology
    • Public Health

  • #2

    University of Washington
    University of Washington

    Seattle, Washington

    Key Differentiators

    • Oncology
    • Medicine

  • #3

    S. Orsola-Malpighi Hospital
    S. Orsola-Malpighi Hospital

    Bologna, Italy

    Key Differentiators

    • Oncology
    • Surgery

  • #4

    New York University Langone Health
    New York University Langone Health

    New York, New York

    Key Differentiators

    • Oncology
    • Surgery

  • #5

    PRECEDE Consortium
    PRECEDE Consortium

    N/A, N/A

    Key Differentiators

    • Oncology
    • Research

Original Source(s)

Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023

  • by Ziyue Wang, Shuai Wang, Guomu Liu, Hao Wu, Yuguo Chen

  • July 15, 2026

Related Content

Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman

Research progress of small molecule targeted drugs for non-small cell lung cancer

The diet-microbiota-inflammation axis and colorectal cancer